Biogen Idec Innovation Incubator (bi3)

bi³ offers the opportunity for entrepreneurial scientists to rapidly convert novel biological insights into life-saving and life-changing therapeutics. Our unique model blends the best of a startup's energy, a venture firm's capital, and a fully-integrated biotech's resources to maximize the chances of scientific, clinical and financial success.

What We Offer

bi³ offers a comprehensive set of resources and services to ensure rapid startup and quick progression to the clinic:

• Funding: bi³ supplies the financial resources necessary to convert "drug prototypes" into development candidates that can quickly enter the clinic in return for pre-negotiated option rights for Biogen Idec.
• Facility: bi³ offers state-of-the-art laboratory space, office space, and shared equipment in an access-controlled environment adjacent to Biogen Idec's headquarters in Cambridge, Massachusetts.
• Focus: bi³ provides important resources that allows founders to stay focused on the science. bi³ companies have access to Biogen Idec's drug discovery expertise, core facilities, scientific services, and world-class technology. bi³ supplies all the business and administrative support required to manage day-to-day company operations.

With these resources in hand, founders are ideally positioned to successfully demonstrate the therapeutic potential of a drug candidate and realize significant economic benefits in only 2 to 3 years.

Visit www.biogenidec.com/bi3 for more information.